Guardant Health (GH) Competitors

Fresenius Medical Care (NYSE:FMS) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, community ranking, institutional ownership, valuation, risk, analyst recommendations and earnings.

Which has more risk and volatility, FMS or GH?

Fresenius Medical Care has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500.

Do analysts rate FMS or GH?

Fresenius Medical Care currently has a consensus price target of $27.80, indicating a potential downside of 6.96%. Guardant Health has a consensus price target of $52.32, indicating a potential upside of 30.89%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts clearly believe Guardant Health is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Guardant Health	0 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	3.05

Do institutionals and insiders believe in FMS or GH?

8.4% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the media refer more to FMS or GH?

In the previous week, Guardant Health had 9 more articles in the media than Fresenius Medical Care. MarketBeat recorded 16 mentions for Guardant Health and 7 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.60 beat Guardant Health's score of 1.36 indicating that Fresenius Medical Care is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Guardant Health	11 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation & earnings, FMS or GH?

Fresenius Medical Care has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care	$19.49B	0.90	$540.07M	$1.12	26.68
Guardant Health	$774.00M	6.40	-$479.45M	-$3.39	-11.79

Is FMS or GH more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Guardant Health's net margin of -59.05%. Fresenius Medical Care's return on equity of 6.04% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care	3.43%	6.04%	2.69%
Guardant Health	-59.05%	-19,157.20%	-25.96%

Does the MarketBeat Community prefer FMS or GH?

Fresenius Medical Care received 119 more outperform votes than Guardant Health when rated by MarketBeat users. However, 71.76% of users gave Guardant Health an outperform vote while only 54.64% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Fresenius Medical Care	Outperform Votes 424 54.64%	Underperform Votes 352 45.36%
Guardant Health	Outperform Votes 305 71.76%	Underperform Votes 120 28.24%

Summary

Guardant Health beats Fresenius Medical Care on 10 of the 19 factors compared between the two stocks.